According to LeMaitre Vascular's latest financial reports the company has a price-to-book ratio of 4.82.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 4.24 | 12.37% |
2022-12-31 | 3.78 | -12.53% |
2021-12-31 | 4.32 | -9.59% |
2020-12-31 | 4.77 | -2.4% |
2019-12-31 | 4.89 | 37.43% |
2018-12-31 | 3.56 | -36.3% |
2017-12-31 | 5.59 | 3.83% |
2016-12-31 | 5.38 | 32.66% |
2015-12-31 | 4.06 | 108.23% |
2014-12-31 | 1.95 | -11.69% |
2013-12-31 | 2.21 | 33.6% |
2012-12-31 | 1.65 | -5.69% |
2011-12-31 | 1.75 | -12.51% |
2010-12-31 | 2.00 | 22.93% |
2009-12-31 | 1.63 | 106.18% |
2008-12-31 | 0.7897 | -59.48% |
2007-12-31 | 1.95 | 7.83% |
2006-12-31 | 1.81 | |
2005-12-31 | N/A | |
2004-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Baxter BAX | 2.46 | -48.97% | ๐บ๐ธ USA |
Boston Scientific BSX | 5.49 | 13.74% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 7.94 | 64.53% | ๐บ๐ธ USA |
Teleflex TFX | 2.24 | -53.58% | ๐บ๐ธ USA |
AngioDynamics ANGO | 0.5860 | -87.85% | ๐บ๐ธ USA |
Cardiovascular Systems CSII | 3.53 | -26.93% | ๐บ๐ธ USA |